查詢結果分析
來源資料
相關文獻
- 攝護腺癌早期診斷指引:摘譯2014年美國泌尿科醫學會評論
- Detection of Prostatic Cancer Using Digital Rectal Examination, Prostate-Specific Antigen and Transrectal Ultrasonography
- Comparison of Transrectal Ultrasound-guided Biopsy of the Prostate and Transurethral Resection of the Prostate for Detection of Prostate Cancer in Patients with Moderate Lower Urinary Tract Symptoms
- Elevated Prostate-specific Antigen in Pleural Effusion: A Case Report
- Flutamide-Induced Liver Injury: A Case Report
- 攝護腺癌之化學藥物治療
- 攝護腺癌的放射線治療及其護理
- Free-to-total Serum Prostate Specific Antigen Ratio in Chinese Men
- 從末期攝護腺癌及乳癌來探討癌症病患荷爾蒙治療法之進展
- Use of a Medical Decision Support System to Improve the Preoperative Diagnosis of Prostate Cancer with Pelvic Lymph Node Metastases
頁籤選單縮合
題名 | 攝護腺癌早期診斷指引:摘譯2014年美國泌尿科醫學會評論=Early Detection of Prostate Cancer: Selective Translation of 2014 American Urological Association Update Series Review |
---|---|
作者姓名(中文) | 黃柏仁; 邱逸淳; | 書刊名 | 北市醫學雜誌 |
卷期 | 12:3 2015.09[民104.09] |
頁次 | 頁207-214 |
分類號 | 415.863 |
關鍵詞 | 攝護腺癌; 攝護腺癌篩檢; 攝護腺特異性抗原; 早期癌症偵測; Prostate cancer; Prostate cancer screening; Prostate specific antigen; PSA; Early detection of cancer; |
語文 | 中文(Chinese) |
中文摘要 | 攝護腺癌是男性常見的惡性腫瘤,而攝護腺特異性抗原指數Prostate specific antigen (PSA)在無症狀男性作為攝護腺癌篩有可能因過度診斷、過度治療而為病人帶來生理及心理的傷害,因此美國泌尿科醫學會於根據大型研究結果,依不同年齡層(小於40歲、40~54歲、55~69歲、70歲以上)制定出攝護腺癌早期診斷指引。本文已獲得美國泌尿科醫學會同意翻譯,作者簡介美國泌尿科醫學會對此指引的內容及討論,希望能提昇醫護人員對攝護腺癌篩檢的重視,提高攝護腺癌的診斷率,同時避免因篩檢所帶來的傷害。 |
英文摘要 | Prostate cancer is a common malignancy in men. Prostate-specific antigen (PSA) screening in asymptomatic men may bring physical and psychological harm to the patients because of overdiagnosis and overtreatment. Therefore, based on the findings on large studies, the American Urological Association formed clinical guidelines for the early detection of prostate cancer according to age groups (age<40; 40 to 54; 55 to 69; ≥70). Through introduction and discussion of the contents, we wish to raise awareness of the importance of prostate cancer screening among medical staff, improve the diagnosis of prostate cancer, and avoid damage brought by the screening. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。